On-Demand Webinars

“Psychedelic Therapy for Mood Disorders: Research & Potential” [Video Replay & Podcast #502]

Access the video replay, listen to the podcast episode (#502), download the slide presentation, and learn how to get a certificate of attendance for this ADHD Experts webinar originally broadcast on Tuesday, April 23, 2024.

ADHD Expert: Adrian Jacques H. Ambrose, M.D., MPH, MBA, FAPA Verified Updated on April 25, 2024
Click to Add Comments

Episode Description

The therapeutic potential of psychedelic drugs for treatment-resistant conditions including mood disorders has sparked renewed interest among researchers, psychiatrists, and patients. New research and ongoing clinical trials are shedding light on the safety and efficacy of these substances, used in controlled therapeutic settings, for conditions that have been challenging to treat using conventional methods. A growing body of research indicates that several classical psychedelics and “psychedelic-like” compounds (e.g. psilocybin, ketamine, MDMA, and LSD) have shown promise for the treatment of substance use disorders, post-traumatic stress disorder (PTSD), anxiety disorders, and treatment-resistant depression (TRD). Some psychedelic treatments, such as MDMA-assisted psychotherapy for PTSD, are currently undergoing phase 3 clinical trials, indicating a significant level of scientific and medical interest in their potential therapeutic applications.

In this webinar, you will learn about:

  • The history of psychedelic therapy and its research
  • The science behind how psychedelic compounds may be targeting clinical conditions, like major depressive disorder
  • The possible benefits and side effects of using psychedelics to conditions after other conventional therapies have failed
  • What questions to ask when considering psychedelic usage in a clinical setting for yourself or loved ones

Watch the Video Replay

Enter your email address in the box above labeled “Video Replay + Slide Access” to watch the video replay (closed captions available) and download the slide presentation.

Treatment for Mood Disorders: More Resources

Obtain a Certificate of Attendance

If you attended the live webinar on April 23, 2024, watched the video replay, or listened to the podcast, you may purchase a certificate of attendance option (cost: $10). Note: ADDitude does not offer CEU credits. Click here to purchase the certificate of attendance option »

Meet the Expert Speaker

Adrian Jacques H. Ambrose, M.D., MPH, MBA, FAPA, is the Senior Medical Director at ColumbiaDoctors Psychiatry at Columbia University Irving Medical Center. For over a decade, Dr. Ambrose has also served as a senior consultant in designing national and global programming in strategy, management, and operations implementation for mid-to-large-sized entities, including Fortune 500 companies. In addition, he specializes in cultivating psychological safety, team building, and culture acceleration for senior managers and executives.

Clinically, Dr. Ambrose specializes in treatment-refractory mood disorders for both the adult, child, and adolescent populations in interventional and novel therapeutics, such as neuronavigated TMS, ketamine, and psychedelics.

Dr. Ambrose completed his medical training at Dartmouth and MGH/McLean Hospital, and value-based healthcare training at the Dartmouth Institute for Health Policy. He also completed the Minority Health Policy Fellowship at Harvard Medical School.

Listener Testimonials

“Excellent information and points about balancing the potential therapeutic uses with the clinical evidence at the moment.”

“Thank you for providing so much info for practitioners! It is very helpful.”

“Great speaker! I would definitely take another of his courses!”

Follow ADDitude’s full ADHD Experts Podcast in your podcasts app:
Apple Podcasts | Google Podcasts | Spotify | Google Play | Amazon Music | RadioPublic | Pocket Casts | iHeartRADIO | Audacy